Charlotte's Web Holdings, Inc. has initiated a long-term scientific collaboration between McLean Hospital, a Harvard Medical School affiliate, to research the efficacy of hemp CBD.
Two distinct clinical trials will be overseen by lead researcher/investigator Dr. Staci A. Gruber, PhD, associate professor of psychiatry at Harvard Medical School and director of the MIND program at McLean Hospital in Belmont, Mass.
These two studies will investigate the efficacy of a custom-formulated, hemp-derived high-CBD product. Funding and product support are provided by the CW Labs division of Charlotte's Web Inc.
Clinical trial results are to be published in 2022. Gruber is also conducting a number of other studies, including a longitudinal observational study of veterans who use a Charlotte's Web product.
Gruber's Marijuana Investigations for Neuroscientific Discovery (MIND) Program, established in 2014, is dedicated to studying the long-term impact of cannabis and cannabinoids for medical and adult use, which utilizes various clinical and cognitive tools as well as multimodal neuroimaging techniques.
"We are honored to be working with Dr. Gruber, Harvard Medical School and McLean Hospital on these important clinical trials," said Tim Orr, president of Charlotte's Web's CW Labs division. "Charlotte's Web remains dedicated to supporting third-party research on hemp CBD investigated by some of the country's top scientists."